BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 10277744)

  • 1. The prognosis for the hospital-based pathologist--Part 1.
    Bierig JR
    Pathologist; 1986 Jul; 40(7):30-3. PubMed ID: 10277744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prognosis for the hospital-based pathologist--Part 2.
    Bierig JR; Dechene JC
    Pathologist; 1986 Aug; 40(8):27-31. PubMed ID: 10278730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What the regulatory developments mean for pathologist-hospital contracts.
    Bierig JR; Dechene JC
    Pathologist; 1984 Sep; 38(9):562-7. PubMed ID: 10273568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathology practice under TEFRA and DRGs.
    Breckenridge RL
    Pathologist; 1983 Aug; 37(8):560-2. PubMed ID: 10310298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Despite ongoing challenges, pathologist reimbursement rules take effect.
    MLO Med Lab Obs; 1984 Mar; 16(3):27, 29. PubMed ID: 10273470
    [No Abstract]   [Full Text] [Related]  

  • 6. Legal considerations in pathologists' contracting-recent developments.
    Polk LT
    Pathologist; 1981 May; 35(5):268-71. PubMed ID: 10251158
    [No Abstract]   [Full Text] [Related]  

  • 7. The pathologist fee crisis--Rx for relief.
    Healy MI
    Case Stud Health Adm; 1980; 2():312-6. PubMed ID: 10250519
    [No Abstract]   [Full Text] [Related]  

  • 8. Administrator and pathologist conflict in contract negotiations.
    Milligan WM
    Case Stud Health Adm; 1980; 2():307-11. PubMed ID: 10250518
    [No Abstract]   [Full Text] [Related]  

  • 9. Negotiating your contract: points to consider.
    Zeiler WB
    Pathologist; 1984 Sep; 38(9):568-71. PubMed ID: 10273569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dr. Derman testifies on MD-DRGs.
    Derman H
    Pathologist; 1986 Aug; 40(8):51-4. PubMed ID: 10311691
    [No Abstract]   [Full Text] [Related]  

  • 11. Lab salaries and benefits. Part I: Are they keeping pace?
    Benezra N
    MLO Med Lab Obs; 1987 Jan; 19(1):30-4. PubMed ID: 10280450
    [No Abstract]   [Full Text] [Related]  

  • 12. The coming of Medicare--a turbulent time for pathology: Part II.
    Coleman FC
    Pathologist; 1981 May; 35(5):272-6. PubMed ID: 10298172
    [No Abstract]   [Full Text] [Related]  

  • 13. Controlling compensation for hospital-based pathologists.
    Van Vorst CB
    Case Stud Health Adm; 1980; 2():317-22. PubMed ID: 10250520
    [No Abstract]   [Full Text] [Related]  

  • 14. The coming of Medicare--a turbulent time for pathology: Part 1.
    Coleman FC
    Pathologist; 1981 Apr; 35(4):216-9. PubMed ID: 10298154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lab salaries and benefits. Part II: Dissatisfaction in the ranks.
    Benezra N
    MLO Med Lab Obs; 1987 Jan; 19(1):37-9. PubMed ID: 10280451
    [No Abstract]   [Full Text] [Related]  

  • 16. Pathologists to challenge Medicare rule.
    Lewis R
    Am Med News; 1983 Apr; 26(14):1, 19. PubMed ID: 10324806
    [No Abstract]   [Full Text] [Related]  

  • 17. Pathologists hope HHS clarification will give them leverage with hospitals.
    Wallace C
    Mod Healthc; 1984 Jun; 14(8):28, 30. PubMed ID: 10273518
    [No Abstract]   [Full Text] [Related]  

  • 18. A cost containment checklist.
    Garcia LS
    MLO Med Lab Obs; 1985 Apr; 17(4):67-8, 71-5. PubMed ID: 10270788
    [No Abstract]   [Full Text] [Related]  

  • 19. Directing the post-TEFRA laboratory.
    Sharp JW
    Pathologist; 1985 Feb; 39(2):15-8. PubMed ID: 10270443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How to manage under prospective payment.
    Sisk FA
    MLO Med Lab Obs; 1987 Apr; 19(4):71-4. PubMed ID: 10312034
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.